1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N0589
    Dehydrodiisoeugenol

    脱氢二异丁香酚

    Inhibitor 99.98%
    Dehydrodiisoeugenol 从 Myristica fragrans Houtt 中分离得到,具有抗炎和抗菌作用。Dehydrodiisoeugenol 抑制 LPS 刺激的小鼠巨噬细胞中 NF-κB 活化和环氧合酶 (COX)-2 基因的表达。
    Dehydrodiisoeugenol
  • HY-P3042
    Chymostatin Inhibitor 99.9%
    Chymostatin 是一种 SARS-CoV-2 Mpro 抑制剂。糜蛋白酶抑制剂上调 endocan 并抑制 NF-κBp65 活性。Chymostatin 可降低 HMGB1 和促炎性细胞因子 (IL-1βIL-6)。Chymostatin 对 Paraquat 引起的急性肺损伤具有保护作用。Chymostatin 对肺癌具有抗癌活性。
    Chymostatin
  • HY-N4187
    Licochalcone D

    甘草查尔酮 D

    Inhibitor 99.80%
    Licochalcone D 是存在于 Glycyrrhiza uralensis 中的黄酮类化合物,是具有口服活性的 NF-κB p65 的有效抑制剂。Licochalcone D 具有抗氧化、抗炎、抗癌等作用。
    Licochalcone D
  • HY-B1278
    D-α-Tocopherol acetate

    生育酚乙酸酯

    Inhibitor 98.32%
    D-α-Tocopherol acetate (D-Vitamin E acetate) 可水解为 d-α-生育酚 (VE) 并被小肠吸收。
    D-α-Tocopherol acetate
  • HY-N2609
    7,4'-Dihydroxyflavone

    7,4'-二羟基黄酮

    Inhibitor 99.64%
    7,4'-Dihydroxyflavone (7,4'-DHF) 是一种类黄酮,可从甘草 Glycyrrhiza uralensis 中分离得到。7,4'-Dihydroxyflavone 是 eotaxin/CCL11CBR1 抑制剂 (IC50=0.28 μM),抑制嗜酸性粒细胞趋化因子产生。7,4'-Dihydroxyflavone 通过调节 NF-κBSTAT6HDAC2 抑制 MUC5A 基因表达和粘液产生。7,4'-Dihydroxyflavone 降低 (PMA) 刺激的 NCI-H292 细胞 MUC5AC 表达,IC50 值为 1.4 μM。
    7,4'-Dihydroxyflavone
  • HY-16172
    DMAPT Inhibitor 98.0%
    DMAPT (Dimethylamino Parthenolide) 是Parthenolide (PTL) 的类似物,是具有口服活性的 NF-κB 抑制剂,对原发性急性髓性白血病细胞的LD50 值为1.7 μM。具有潜在的抗肿瘤和抗转移作用。
    DMAPT
  • HY-N0222
    Avicularin

    扁蓄苷; 蓄苷

    Inhibitor 99.80%
    Avicularin 是一种具有口服活性的黄酮类化合物。Avicularin 抑制 NF-κB (p65) , COX-2PPAR-γ 的活性。Avicularin 具有抗炎、抗感染、抗过敏、抗氧化、保肝、抗肿瘤等作用。
    Avicularin
  • HY-P99143
    Anti-Mouse NK1.1 Antibody (PK136) Inhibitor
    Anti-Mouse NK1.1 Antibody (PK136) 是一种抗小鼠 NK1.1 IgG2a 单克隆抗体。Anti-Mouse NK1.1 Antibody (PK136) 可以耗竭自然杀伤 (NK) 细胞。Anti-Mouse NK1.1 Antibody (PK136) 抑制 JAK-STATNF-κB 信号通路。Anti-Mouse NK1.1 Antibody (PK136) 可用于研究炎症疾病,如非酒精性脂肪性肝炎 (NASH)。
    Anti-Mouse NK1.1 Antibody (PK136)
  • HY-N0919
    Yangonin

    甲氧醉椒素

    Inhibitor 99.65%
    Yangonin 对人重组大麻素 CB1 受体具有高的亲和力,IC50Ki 分别为 1.79 μM 和 0.72 μM。
    Yangonin
  • HY-W040055
    Neopterin

    新蝶呤

    Inhibitor 99.05%
    Neopterin 是一种 GTP 代谢的免疫系统激活剂,可由活化巨噬细胞产生。Neopterin 具有抗血管炎症和抗动脉粥样硬化的潜力。Neopterin 抑制 NF-κB 磷酸化、促进 PPAR-γ 表达,从而抑制血管内皮细胞炎症反应、减少巨噬细胞泡沫细胞形成,并调节血管平滑肌细胞的迁移和增殖。Neopterin 可用于心血管疾病 (如动脉粥样硬化)、炎症相关疾病及肿瘤免疫监测等领域的研究。
    Neopterin
  • HY-N1365
    Isoscopoletin

    异东莨菪素

    Inhibitor 99.92%
    Isoscopoletin (6-Hydroxy-7-methoxycoumarin) 是艾叶中的一种活性成分。 Isoscopoletin 具有显著的细胞增殖抑制作用,对人类 CCRF-CEM 白血病细胞和耐药亚系 CEM/ADR5000 作用的 IC50 值分别为 4.0 μM 和 1.6 μM。Isoscopoletin (6-Hydroxy-7-methoxycoumarin) 具有抑制 HBV 复制的活性。Isoscopoletin 通过抑制 MAPK/NF-κB/STAT/AKT 信号通路发挥抗氧化活性。
    Isoscopoletin
  • HY-N5142
    α-Terpineol

    α-松油醇

    Inhibitor 99.47%
    α-Terpineol 可在蓝桉 (Eucalyptus globulus Labill) 中被发现,具有口服活性。α-Terpineol 对牙周病和致龋菌具有很强的抗菌活性。此外,α-Terpineol 还具有抗真菌活性 (T. mentagrophytes),这种活性可能导致不可逆转的细胞分裂。同时,α-Terpineol 具有抗神经疼痛和抗炎活性。α-Terpineol 可用于腹泻、神经性疼痛、感染、炎症、代谢等领域的研究。
    α-Terpineol
  • HY-N3021
    D-chiro-Inositol

    D-手性肌醇

    Inhibitor 98.0%
    D-chiro-Inositol 是一种肌醇的差向异构体,具有改善糖代谢、抗肿瘤、抗炎和抗氧化的活性。D-chiro-Inositol 通过改善胆汁酸分泌和减轻氧化应激,有效缓解胆汁淤积。它通过模拟胰岛素的作用来改善胰岛素抵抗,降低高血糖和循环胰岛素水平,减少血清雄激素,并改善 X 综合征的一些代谢异常。此外,D-chiro-Inositol 可诱导促炎因子 (如 Nf-κB) 和细胞因子 (如 TNF-α) 的减少,从而发挥抗炎作用。D-chiro-Inositol 可用于肝硬化、乳腺癌、2 型糖尿病和多囊卵巢综合征的研究。
    D-chiro-Inositol
  • HY-155998
    NF-κB-IN-11 Inhibitor 98.42%
    NF-κB-IN-11 (Compound 3i) 是一种 NF-κB 抑制剂。NF-κB-IN-11 抑制 TNF-α 诱导的 NF-κB 通路激活,并抑制 NF-κB 的核转位。NF-κB-IN-11 下调磷酸化-IKK、IκBα 和 NF-κB p65 的表达水平。NF-κB-IN-11 具有抗炎活性,可减轻葡聚糖硫酸钠诱导的小鼠结肠炎。NF-κB-IN-11 (口服) 在小鼠急性毒性测定中显示 MTD 超过 1852 mg/kg。
    NF-κB-IN-11
  • HY-100581
    CORM-3
    CORM-3 是一种 CO 释放分子,能减弱 NF-κB p65 的核异位,减少 ROS 的生成,并提高细胞内谷胱甘肽和超氧化物歧化酶的水平。CORM-3 可减少 NLRP3 炎症小体的激活
    CORM-3
  • HY-N0762
    Isobavachin

    异补骨脂二氢黄酮

    Inhibitor 99.88%
    Isobavachin 是可从 Psoralea corylifolia 中分离得到的一种抗氧化剂,在A环的8号位置有一个prenyl基团,它可以促进神经元的分化和其蛋白异戊烯化的潜在作用。
    Isobavachin
  • HY-124179
    IT-901 Inhibitor 99.32%
    IT-901 是一种具有口服活性且有效的 NF-κB 亚基 c-Rel 抑制剂,对 NF-κBc-Rel 与 DNA 结合的 IC50 分别为 0.1 μM,3 μM。IT-901 是一种具有生物活性的萘硫代巴比妥酸酯衍生物,具有用于人类淋巴瘤和改善移植物抗宿主病 (GVHD) 的潜力。
    IT-901
  • HY-10072
    SPC 839 Inhibitor 99.86%
    SPC 839 (compound 10) 是一种具有口服活性的 AP-1NF-kB 介导的转录激活抑制剂,其 IC50 值为 0.008 μM。
    SPC 839
  • HY-N1419
    Vaccarin

    王不留行黄酮苷

    Inhibitor 98.47%
    Vaccarin 是一种具有口服活性和多种生物学功能活性类黄酮糖苷。Vaccarin 通过激活 AKTERK 促进新血管形成。Vaccarin 可激活 AMPK 信号通路改善胰岛素抵抗和脂肪变性。Vaccarin 是一种 MAPKNF-κBNFAT 抑制剂,有效阻断 RANKL 诱导的破骨细胞形成。
    Vaccarin
  • HY-N2350
    Cynaropicrin

    菜蓟苦素

    Inhibitor 99.79%
    Cynaropicrin 是一种倍半萜内酯,可以抑制肿瘤坏死因子 (TNF-α) 的释放,在鼠和人巨噬细胞的 IC50 值分别为 8.24 和 3.18 μM。 Cynaropicrin 也抑制软骨降解因子 (MMP13) 的增加并抑制 NF-κB 的信号传导。
    Cynaropicrin
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.